Going to be fda approved and going to new highs.

Absolutely revolutionary FDA $1.00 moving up.

FDA pre approvel, best TRENDING stock of the moment!

$KALA is the one up 500% on Phase 2 results where FDA approval of any possible kind is many years away and where the company is burning through $80 million per year for zero results.

$KALA Great calls in our discord all week and also running on great FDA news. https://youtu.be/7CvA--rrXpk

$KALA More to come: MW Kala Pharmaceuticals stock up 750% in 3 days after upbeat FDA news on PCED treatment

$KALA FDA approved!

the FDA gives a thumbs up or thumbs down and you keep moving ahead

$EDSA love love love this stock — another billion dollar medication, for covid, FDA expected soon.

Great start to the week $NAOV went operation moon on that headline from the FDA, $DBGI continuation play with a crazy move.

This is 100% normal and part of the growth of a strong company with excellent fundamentals and an FDA approval coming this year.

$ARDX very good fda news on this conference call

And this is just a beginning, FDA approval will take it to the skies.

Pretty Bullish ER going to give us an update on FDA when and etc. .

If the trend of script numbers is anything to go by, guidance could be way better than Wall Street expects giving us a nice boost before FDA news.

$AKBA within 3 to 4 weeks this stock could be over 2 heading to three like $ARDX .. gsk approval has helped.. fda news, ema opinion/ approval, partnership..

$ARDX when we get fda approval will be shining

This should be seen as a REALLY good thing - because they will need cashflow soon - one would expect - assumption being FDA response is close and production and marketing is about to get kicked up a notch. .

Things to look forward to.. NDA refile announcement, Q4 results, weekly IBSRELA sales increasing now that we are through the holidays, FDA approval, Japan approval, launch of Xphozah.

They just got approval for 1 drug from FDA and things are bot going well there..

Only FDA EMA approved oral drug for LN w 3 years safety history, which shows clear improvement in eGFR compared to placebo.

I think this drug will likely be BO before FDA APPROVAL 13% up just for today!